Personal Injury Lawyer - TheLawfirm.com

Free case review

1-855-464-0808
facebook logo google+ logo twitter logo youtube logo

Free Case Review

blank-spacer

 

Lawsuit against lipitor, effexor and pfizer revived

Lipitor, Effexor Antitrust Suit against Pfizer Renewed

August 23, 2017
The Third Circuit Court has revived a fraud and antitrust suit against Pfizer and generic-drug maker Ranbaxy over the cholesterol-control drugs Lipitor and Effexor.

The court ruled that plaintiffs’ claims in the Multi-District Litigation (MDL) case are plausible. Plaintiffs allege that the defendants have artificially inflated the costs of the drugs. Specifically, Pfizer is accused of fraudulently procuring and enforcing a Lipitor patent and of an illegal reverse payment to Ranbaxy to keep a generic off the market; Pfizer subsidiary Wyeth is accused of patent fraud for Effexor XR and of an illegal reverse payment to Teva. 

Multiple billions of dollars of drug sales are now under question, and the decision is seen as a major blow to the drugmakers, as the claims had previously been dismissed entirely.

The case is an enormously complex one, involving reversals of previous decisions and a host of drug companies. Centrally, though, the companies could stand to lose billions – not to mention credibility.

If you believe that your prescription medications have been subject to unfair price hikes, you may be able to participate in a lawsuit that would help you right that wrong. Contact TheLawFirm.com to learn how we can help you with your case.

Talk with aN Attorney now!


Related Articles


VA urged to address risks of opioids for veterans
More states added to lawsuit against opioid makers
Drugstores try to block cherokee opioid lawsuit
Insys settles Illinois opioid lawsuit
Opioid epidemic
Insys Blue Cross and Blue Shield lawsuit
Fentanyl likely cause of boys death
FDA urged to block opioid suppliers
Painkiller Opana
Opioid Atty Gen
FDA urged to remove opioids from market
FDA urges Opana to be pulled from the shelves
FDA warning
Oxycontin secret marketing
FDA approved drugs
FDA denies use of blue dye in opioids
FDA faults Canadian drugmaker for opioid abuse
Opioid lawsuit settlement
Opioids causing National epidemic
Opioid privileges revoked

Talk with aN Attorney now!

TheLawFirm.com’s award winning lawyers have been featured in over 50 radio and television interviews including: tv station logos

Real lawyers, real results!

no recovery, no fee!

SHARE THIS